Linagliptin and metformin hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72205-407 -
Package NDC
72205-407-01 -
Package NDC
72205-407-02 -
Application number
ANDA208459 -
SPL ID
5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb -
SPL set ID
5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb -
UNII
3X29ZEJ4R2 -
UNII
786Z46389E -
RxCUI
1243020 -
RxCUI
1243027 -
RxCUI
1243034
What the source publishes
- Labeler
- Novadoz Pharmaceuticals LLC
- Active ingredients
- Linagliptin and metformin hydrochloride
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Linagliptin and metformin hydrochloride",
"splId": "5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb",
"labels": [
{
"setId": "5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb"
}
],
"routes": [
"ORAL"
],
"labeler": "Novadoz Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01)",
"package_ndc": "72205-407-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20251104"
},
{
"sample": false,
"description": "180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02)",
"package_ndc": "72205-407-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20251104"
}
],
"productId": "72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "72205-407",
"deaSchedule": null,
"genericName": "Linagliptin and metformin hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LINAGLIPTIN",
"strength": "2.5 mg/1"
},
{
"name": "METFORMIN HYDROCHLORIDE",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA208459",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20251103",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175912",
"N0000175913"
],
"upc": [
"0372205408029",
"0372205407015",
"0372205409019",
"0372205407022",
"0372205409026",
"0372205408012"
],
"unii": [
"3X29ZEJ4R2",
"786Z46389E"
],
"rxcui": [
"1243020",
"1243027",
"1243034"
],
"spl_set_id": [
"5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb"
],
"pharm_class_epc": [
"Dipeptidyl Peptidase 4 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Dipeptidyl Peptidase 4 Inhibitors [MoA]"
],
"manufacturer_name": [
"Novadoz Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb"